Shri Pradip Mukherjee

A notable achievement, in view of the COVID-19 restrictions, was the processing of nearly 8 MCi of Co-60 at RAPPCOF, Kota which was greater than double the average volume since the last five years. Expansion of RAPPCOF Facility (ERF), Kota, on completion, shows promise of a multifold increase in the commercial production of high-intensity Co-60 Sealed Sources and the Bhoomi Poojan ceremony was recently performed at the site.

BRIT continues to provide affordable cancer care worldwide and has emerged as a leading supplier of Co-60 teletherapy sealed sources. As a leading exporter of irradiator source pencils, BRIT exported 3 MCi of Co-60 Irradiator Sources to Canada and Malaysia. This was in addition to the domestic supply of ~3.5 MCi of Co-60 Irradiator Sources which find myriad applications in disinfestation, shelf-life extension of food products and sterilization of healthcare products.

Building on the strengths of BRIT’s technical capabilities, several MoUs were signed with private entrepreneurs for setting up of Gamma Radiation Processing Facilities. BRIT assisted in the commissioning of Radiation Processing Plants (05 nos.) during this year and a total of 32 Radiation Processing Facilities - under MoU with BRIT - are currently in operation in India.

BRIT’s commitment to excellence in the delivery of all products, pan-India, has received appreciation from its customers and BRIT has extended this trajectory by registering as a seller in Government e-Marketplace (GeM) thus enhancing its customer reach. The Azadi ka Amrit Mahotsav (AKAM) outreach program was enthusiastically celebrated by BRIT (10th - 24th August 2022) and all the events conducted were highly commended by all visitors as well as the participating schools and colleges.

BRIT’s mandate of fulfilling customer expectations has led to channeling of its efforts deeper into areas which are its strengths an example of which is the Mobile Food Irradiator (MFI). This was successfully designed and has received DAE approval. Construction will commence shortly, following approval from AERB. Several other projects have been sanctioned for revamping of the existing infrastructure, modernization of Radiopharmaceuticals Facility and development of new radiation technology equipment.

BRIT’s journey will continue to leverage the benefits of the various improvements made in 2022 in terms of customer reach, product portfolio and new partnerships as it steps into the future with many new aspirations. I am filled with optimism and energy on the advent of the New Year and wish you all a very happy 2023!

Jai Hind!